What’s Happening With Edward Lifesciences Stock?

by Trefis Team
Rate   |   votes   |   Share

[Updated: Sep 17, 2021] Edward Lifesciences Stock Update

A few months back we discussed that Edward Lifesciences (NYSE:EW) stock may continue to see higher levels after rising 10% in a month following the positive developments around Resilia tissue valves. EW stock has since rallied 16% to levels of $121 currently. In late July the company reported its Q2 results that were comfortably above the consensus estimates, driven by increased transcatheter aortic valve replacement procedure volume. Also, the company raised its full-year outlook for revenues and earnings to grow at a higher pace than earlier anticipated, and this has boded well with the investors.

But now that EW stock has seen a 6% move over the last month or so, while it is up 36% year-to-date, will it continue its upward trajectory, or is a fall imminent? Going by historical performance, there are still higher chances of a rise in EW stock over the next month. Out of 767 instances in the last ten years that EW stock saw a twenty-one day rise of 6% or more, 477 of them resulted in EW stock rising over the subsequent one-month period (twenty-one trading days). This historical pattern reflects 477 out of 767, or about a 62% chance of a rise in EW stock over the coming month. See our analysis on Edward Lifesciences Stock Chances of Rise for more details.

Calculation of ‘Event Probability‘ and ‘Chance of Rise‘ using last ten years data

  • After moving -1.4% or more over a five-day period, the stock rose in the next five days on 61% of the occasions.
  • After moving 3.3% or more over a ten-day period, the stock rose in the next ten days on 58% of the occasions
  • After moving 5.8% or more over a twenty-one-day period, the stock rose in the next twenty-one days on 62% of the occasions.

Predict average return on Edwards Lifesciences (EW) Stock Return: AI Predicts EW Average and Excess Return After a Fall or Rise

Edwards Lifesciences (EW) Stock Return (Recent) Comparison With Peers

  • Five-Day Return: BAX highest at 1%; MDT lowest at -2.6%
  • Ten-Day Return: BAX highest at 9.6%; ZBH lowest at -3%
  • Twenty-One Day Return: BAX highest at 10%; ZBH lowest at -0.4%

 

[Updated: Jun 25, 2021] EW Stock Rise

The stock price of Edward Lifesciences (NYSE:EW), a company specializing in artificial heart valves and hemodynamic monitoring, has seen a rise of 10% in the last twenty-one trading days. This can be attributed to the positive outcome from a clinical trial for Evoque tricuspid and Pascal system for patients impacted by mitral or tricuspid heart valve disease. Furthermore, the company has seen strong adoption of its Resilia tissue valves in the recent past, a trend expected to continue going forward. Earlier this month, the company announced the U.S. FDA approval for its Acumen Hypotension Prediction Index software with the Acumen IQ finger cuff, which provides access to various hemodynamic parameters. The software uses machine learning to send alerts if a patient is having a low blood pressure.

While there have been some positive developments for the company of late, now that EW stock has seen a rise of 10% in twenty-one trading days, will it continue its upward trajectory, or is a fall imminent? Going by historical performance, there is a higher chance of a rise in EW stock over the next month. Out of 387 instances in the last ten years that Edwards Lifesciences stock saw a twenty-one day rise of 10% or more, 228 of them resulted in EW stock rising over the subsequent one month period (twenty-one trading days). This historical pattern reflects 228 out of 387, or about 59% chance of a rise in EW stock over the coming month. See our analysis on Edwards Lifesciences Stock Chances of Rise for more details.

Calculation of ‘Event Probability‘ and ‘Chance of Rise‘ using last ten year data

  1. After moving 4.6% or more over a five-day period, the stock rose in the next 5 days on 51% of the occasions.
  2. After moving 7.9% or more over a ten-day period, the stock rose in the next 10 days on 54% of the occasions
  3. After moving 9.8% or more over a twenty-one-day period, the stock rose in the next 21 days on 59% of the occasions

Predict average return on Edwards Lifesciences (EW) Stock Return: AI Predicts EW Average and Excess Return After a Fall or Rise

Edwards Lifesciences (EW) Stock Return (Recent) Comparison With Peers

  • Five-Day Return: EW highest at 4.6%; BAX lowest at -1%
  • Ten-Day Return: EW highest at 7.9%; BAX lowest at 1.7%
  • Twenty-One Day Return: EW highest at 9.8%; ABT lowest at -5.5%

While EW stock may see higher levels, 2020 has created many pricing discontinuities which can offer attractive trading opportunities. For example, you’ll be surprised how counter-intuitive the stock valuation is for Merck vs. Regeneron

Invest with Trefis Market Beating Portfolios
See all Trefis Price Estimates
Rate   |   votes   |   Share

Comments

Name (Required)
Email (Required, but never displayed)
Be the first to comment!